Since our founding in January, 2007, ChinaBio® LLC has rapidly created a broad platform of capabilities connecting China life science with the world. We have helped large, multinational companies such as Pfizer, Roche and Life Technologies, and smaller China domestic companies achieve success in China. We have organized more than 20 conferences in China, the U.S. and Europe, and have generated more than $400M in funding for our participants and clients. We have also built the most extensive knowledgebase and publish the most widely read newsletter on the China life science industry, ChinaBio® Today.
Shanghai's Ultra-Modern Skyline
Our team of industry consultants, analysts and advisors based in Shanghai, San Diego and Silicon Valley make ChinaBio Your trusted partner in China life science™.
ConsultingChinaBio® provides a wide range of services to help entrepreneurs, investors, big pharma and other MNCs achieve success in China. If you are a U.S. life science company looking to establish relationships or operations in China, or a China company seeking investors or partners in the U.S., ChinaBio® has the expertise and talent to help.
China strategy development
Market / competitive analysis
Technology and partner searches
Partner selection and management
Funding strategy and assistance
ConferencesChinaBio® has established a reputation for organizing the premier life science investment and partnering conferences in China. Our ChinaBio® Investor Forums have helped China companies raise over $400M in funding. Our new ChinaBio® Partnering Forum, the first partnering event held in China, attracted over 500 attendees. And now we're expanding our events by working with key partners to organize custom events to meet their specific needs.
ChinaBio® has created ChinaBio Capital Partners (CBCP) specifically to address the need for strategic and financial advisory services. As the only merchant bank focused exclusively on China's life science industry, CBCP is uniquely positioned to help U.S. and western companies acquire companies and technologies in China, and China life science companies secure strategic partners in the west and raise funds domestically and internationally.
Our end-to-end services include:
Raise government and VC funding
In-license/out-license novel technologies
Acquisition searches
Negotiate and close M&A transactions
Establish JV or subsidiary company in China
Interface with government agencies
Taking transactions from search through negotiation to close
ChinaBio® has assembled a comprehensive picture of China's life science landscape. Whether you're seeking the next technology, a research partner, or a company to manufacture your latest drug or device, ChinaBio® can quickly assess the market identify the partner or technology you're seeking, leveraging our proprietary information and databases.
We track a wide range of industry data:
Government research funding
Novel technology / drug development
Clinical trial activity
VC investments and IPOs
M&A and partnering deals
And have developed numerous proprietary databases:
ChinaBio® Todayis an email and online newsletter focusing exclusively on the rapidly evolving biotech and life science industries in China. From our offices in Shanghai and California, we provide daily news, commentary and analysis on public and private China life science companies and industry events, as well as global issues affecting the China life science market to over 18,000 readers.
